Canzon Israel Ltd Market Cap ($1.71 Million)
Market Cap & Net Worth: Canzon Israel Ltd (CNZN)
Canzon Israel Ltd market cap. Canzon Israel Ltd (TA:CNZN) has a market capitalization of $1.71 Million (ILA638.39 Million) as of November 1, 2026. Listed on the TA stock exchange, this Israel-based company holds position #30212 globally and #439 in its home market, demonstrating a -16.11% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Canzon Israel Ltd's stock price ILA155.20 by its total outstanding shares 4113310 (4.11 Million). Also see CNZN operating cash flow for how efficiently the company converts equity into cash flow.
Canzon Israel Ltd Market Cap History (2015–2026)
Canzon Israel Ltd market cap history from 2015 to 2026. Data shows change from $2.81 Billion to $1.71 Million (-49.97% CAGR). Check latest Canzon Israel Ltd stock price today for real-time trading data and today's change.
Canzon Israel Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Canzon Israel Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Canzon Israel Ltd (CNZN) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
19.83x
Canzon Israel Ltd's market cap is 19.83 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.81 Billion | $12.03 Million | -$1.29 Million | 233.33x | N/A |
| 2016 | $2.09 Billion | $13.29 Million | $280.00K | 157.28x | 7463.35x |
| 2017 | $788.48 Million | $4.07 Million | $122.00K | 193.68x | 6462.92x |
| 2019 | $10.29 Million | $24.00K | -$55.99 Million | 428.70x | N/A |
| 2020 | $8.82 Million | $277.00K | -$12.32 Million | 31.85x | N/A |
| 2021 | $4.96 Million | $59.00K | -$3.11 Million | 84.11x | N/A |
| 2022 | $4.56 Million | $1.19 Million | -$3.80 Million | 3.83x | N/A |
| 2023 | $1.96 Million | $99.00K | -$4.74 Million | 19.83x | N/A |
Competitor Companies of CNZN by Market Capitalization
Companies near Canzon Israel Ltd in the global market cap rankings as of November 1, 2026. Also see total assets of Canzon Israel Ltd for a full breakdown of the balance sheet.
Key companies related to Canzon Israel Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #535 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #593 globally with a market cap of $45.23 Billion USD ( CN¥309.13 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #511 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #535 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.62 |
| #593 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.23 Billion | CN¥48.46 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.30 |
Market Capitalization of Canzon Israel Ltd (2015–2026)
Market capitalization of Canzon Israel Ltd from 2015 to today. Between 2015 and today, Canzon Israel Ltd's market cap moved from $2.81 Billion to $ 1.71 Million, with a yearly change of -49.97%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA1.71 Million | +29.33% |
| 2025 | ILA1.32 Million | +9.09% |
| 2024 | ILA1.21 Million | -38.20% |
| 2023 | ILA1.96 Million | -56.97% |
| 2022 | ILA4.56 Million | -8.07% |
| 2021 | ILA4.96 Million | -43.75% |
| 2020 | ILA8.82 Million | -14.26% |
| 2019 | ILA10.29 Million | -96.56% |
| 2018 | ILA299.40 Million | -62.03% |
| 2017 | ILA788.48 Million | -62.27% |
| 2016 | ILA2.09 Billion | -25.54% |
| 2015 | ILA2.81 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Canzon Israel Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.71 Million USD |
| MoneyControl | $1.71 Million USD |
| MarketWatch | $1.71 Million USD |
| marketcap.company | $1.71 Million USD |
| Reuters | $1.71 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Canzon Israel Ltd
Canzon Israel Ltd focuses on investing and managing projects in the field of initiating construction for residential and commercial purposes in Portugal. The company was formerly known as User Trend Ltd and changed its name into Canzon Israel Ltd in June 2019. Canzon Israel Ltd was incorporated in 1999 and is based in Tel Aviv, Israel.